MH

Matthias Hebben

Chief Technology Officer

Complement Therapeutics


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Complement Therapeutics
Industry
biotechnology
Employees
33.0
Seniority
C suite
Annual Revenue
1000000.0
Total Funding
84807330.0
Latest Funding
Series A

Technologies

Outlook MailChimp SPF Microsoft Office 365 Salesforce Remote Basis

Keywords

complement system complement medicine therapeutic development gene therapy protein therapy amd treatment age-related macular degeneration geographic atrophy systemic diseases clinical trials preclinical development fhr proteins complement dysregulation precision medicine systemic blood sample analysis mass spectrometry platform patient stratification disease monitoring complement-mediated diseases innovative therapies clinical needs immune system ocular diseases translational research therapeutic approaches novel therapeutics aav gene therapies drug discovery chronic renal disease neurological conditions multiple sclerosis alzheimer's disease pathogenesis research complement inhibition scientific expertise market needs biopharmaceutical solutions biotech startup environment platform technology cell therapy impact of genetic variants research collaborations clinical focus drug innovation complement precision medicine platform scalable manufacturing processes medical advisory board investor partnerships health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans